Beard, C
Donahue, R J
Dillon, D G
Van't Veer, A
Webber, C
Lee, J
Barrick, E
Hsu, K J
Foti, D
Carroll, F I
Carlezon Jr, W A
Björgvinsson, T
Pizzagalli, D A
Article History
Received: 6 January 2015
Revised: 3 March 2015
Accepted: 24 March 2015
First Online: 12 May 2015
Competing interests
: WAC discloses that he is an inventor on a patent that claims the use of kappa-opioid receptor antagonists for the treatment of depression (assignee: McLean Hospital), and over the past 2 years he has received compensation for editorial duties from the American College of Neuropsychopharmacology. FIC is an inventor of US patents claiming the composition of JDTic owned by the Research Triangle Institute. Over the past 2 years, DAP has received consulting fees from Otsuka America Pharmaceutical, Pfizer and Servier for activities unrelated to the current research. All the remaining authors declare no conflict of interest.